Jazz Pharmaceuticals Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	1,392	2,413	1,506	881.48	591.45
Short-Term Investments	1,050	580	120	-	-
Cash & Short-Term Investments	2,442	2,993	1,626	881.48	591.45
Cash Growth	-18.41%	84.03%	84.50%	49.04%	-59.33%
Accounts Receivable	830.75	716.77	705.79	651.49	563.36
Inventory	416.96	480.45	597.04	714.06	1,073
Other Current Assets	476.44	438.95	506.29	359.1	383.81
Total Current Assets	4,166	4,629	3,435	2,606	2,611
Net Property, Plant & Equipment	258.74	227	234.99	301.38	343.42
Other Intangible Assets	4,430	4,756	5,418	5,794	7,152
Goodwill	1,829	1,716	1,753	1,693	1,828
Other Long-Term Assets	975.71	684.22	551.78	440.64	363.95
Total Assets	11,659	12,012	11,393	10,835	12,299
Accounts Payable	122.06	77.87	102.75	90.76	100.3
Accrued Expenses	1,034	910.95	793.91	803.26	666.3
Current Portion of Long-Term Debt	1,030	31	604.95	31	31
Unearned Revenue	-	-	-	0.46	2.09
Other Current Liabilities	56.39	18.76	35.07	7.72	9.61
Total Current Liabilities	2,243	1,039	1,537	933.19	809.3
Long-Term Debt	4,328	6,078	5,108	5,693	6,019
Long-Term Leases	50.89	38.94	59.23	71.84	87.2
Other Long-Term Liabilities	718.99	763.35	952.46	1,051	1,418
Total Long-Term Liabilities	5,098	6,880	6,120	6,816	7,524
Total Liabilities	7,341	7,919	7,656	7,750	8,333
Common Stock	0.06	0.06	0.06	0.06	0.06
Additional Paid-in Capital	4,241	3,914	3,700	3,478	3,535
Accumulated Other Comprehensive Income	-568.6	-947.67	-842.15	-1,126	-400.36
Retained Earnings	646.18	1,127	878.66	733.59	830.23
Shareholders' Equity	4,319	4,094	3,737	3,086	3,965
Total Liabilities & Equity	11,659	12,012	11,393	10,835	12,299
Total Debt	5,409	6,148	5,772	5,796	6,137
Net Cash (Debt)	-2,967	-3,155	-4,146	-4,915	-5,546
Net Cash Per Share	-48.66	-47.79	-57.53	-78.59	-92.90
Book Value	4,319	4,094	3,737	3,086	3,965
Book Value Per Share	70.82	62.02	51.86	49.34	66.43
Tangible Book Value	-1,940	-2,378	-3,434	-4,401	-5,015
Tangible Book Value Per Share	-31.82	-36.03	-47.65	-70.38	-84.01

Updated Feb 24, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q